IntAct European Bioinformatics Institute IntAct intact http://www.ebi.ac.uk/ http://www.ebi.ac.uk/intact/query/${ac} EBI-[0-9]+|IA:[0-9]+ INTerAction database (IntAct) provides an open source database and toolkit for the storage, presentation and analysis of molecular interactions. http://www.ebi.ac.uk/intact European Bioinformatics Institute; Wellcome Trust Genome Campus; Hinxton, Cambridge; CB10 1SD; United Kingdom http://www.ebi.ac.uk/intact/ Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Proceedings of the National Academy of Sciences of the United States of America 2017 imex curation Sevrioukova IF., Poulos TL. sevrioui@uci.edu 30-Aug-2019: Contacted by IntAct-Help. Only protein-protein interactions imex curation in vitro In vitro uv-vis ultraviolet-visible spectroscopy uv-vis predetermined predetermined participant predetermined Phosphate concentration mol mole 0.6 0.1 Sevrioukova IF., Poulos TL. sevrioui@uci.edu Accepted 2019-AUG-08 AT 14:25 BST AT 14:25 BST by MGT Proceedings of the National Academy of Sciences of the United States of America 2017 Only protein-protein interactions imex curation imex curation Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Proceedings of the National Academy of Sciences of the United States of America 2017 imex curation Sevrioukova IF., Poulos TL. sevrioui@uci.edu 30-Aug-2019: Contacted by IntAct-Help. Only protein-protein interactions imex curation in vitro In vitro x-ray diffraction x-ray crystallography X-ray X-ray x-ray diffraction predetermined predetermined participant predetermined Sevrioukova IF., Poulos TL. sevrioui@uci.edu Accepted 2019-AUG-08 AT 14:25 BST AT 14:25 BST by MGT Proceedings of the National Academy of Sciences of the United States of America 2017 Only protein-protein interactions imex curation imex curation midazolam midazolam Buccolam Dormicum mezolam midazolam midazolamum 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine small molecule small molecule chemical synthesis Chemical synthesis (Chemical synthesis) heme b Heme b small molecule small molecule chemical synthesis Chemical synthesis (Chemical synthesis) cp3a4_human Cytochrome P450 3A4 Albendazole monooxygenase (sulfoxide-forming) CYP3A4 CYP3A3 Albendazole sulfoxidase CYPIIIA3 CYPIIIA4 Cytochrome P450 3A3 Cytochrome P450 HLp Cytochrome P450 NF-25 Cytochrome P450-PCN1 Nifedipine oxidase Quinine 3-monooxygenase 1,8-cineole 2-exo-monooxygenase Cholesterol 25-hydroxylase 1,4-cineole 2-exo-monooxygenase protein protein human Homo sapiens Human MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA 38ED122BF89F74F7 cyp3a4-midazolam-1 4 5 unspecified role unspecified role neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) 7 unspecified role unspecified role neutral component neutral component purified purified region sufficient to bind sufficient binding region sufficient to bind certain certain sequence position certain certain certain sequence position certain ecoli Escherichia coli (strain K12) 6 cofactor cofactor coenzyme neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) direct interaction direct interaction Table S1 2.7Å Rwork: 0.224 Rfree: 0.292 cyp3a4-midazolam-2 1 7 unspecified role unspecified role neutral component neutral component purified purified P08684:p.Ser119Ala mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain S A At 0.6 Mol phosphate concentration, Kd changes to 6.2x10^-6 ~0.60 molar Tue Jun 30 17:35:26 BST 2020 This feature has been corrected as a result of our quality control procedures. The original label was 'p.Ser119Ala' ecoli Escherichia coli (strain K12) 6 cofactor cofactor coenzyme neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) 5 unspecified role unspecified role neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) direct interaction direct interaction 3 Fig. 2 cyp3a4-heme b-1 1 7 unspecified role unspecified role neutral component neutral component purified purified P08684:p.Ser119Ala mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain S A Tue Jun 30 18:26:31 BST 2020 This feature has been corrected as a result of our quality control procedures. The original label was 'p.Ser119Ala' ecoli Escherichia coli (strain K12) 6 cofactor cofactor coenzyme neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) 5 unspecified role unspecified role neutral component neutral component purified purified chemical synthesis Chemical synthesis (Chemical synthesis) direct interaction direct interaction 2 Fig. 2